Literature DB >> 24869632

Prodromal symptoms and early detection of Parkinson's disease in general practice: a nested case-control study.

Annette O A Plouvier1, Renier J M G Hameleers2, Eva A J van den Heuvel2, Hans H Bor2, Tim C Olde Hartman2, Bastiaan R Bloem3, Chris van Weel4, Antoine L M Lagro-Janssen2.   

Abstract

BACKGROUND: Timely diagnosis of Parkinson's disease (PD), facilitating early intervention, depends largely on the GP's awareness of early symptomatology. For general practice, it is unknown which prodromal symptoms (symptoms preceding the typical motor symptoms of PD) demand the GP's alertness.
OBJECTIVE: To assess prodromal symptoms that should alert the GP to the possibility of PD in primary care patients.
METHODS: A nested case-control study was carried out in a population of approximately 12000 patients registered in the Continuous Morbidity Registration database affiliated with the University of Nijmegen in the Netherlands. The database pools subject data from four primary care practices. The subjects comprised all 86 patients diagnosed with PD between 1972 and 2007, and 78 controls, matched by sex, age, socioeconomic status and primary care practice. The primary measures of outcome were the prodromal symptoms presenting in the two years prior to the diagnosis of PD. The number (and type) of referrals and diagnostic tests were also assessed.
RESULTS: In the two-year period prior to diagnosis, PD patients more often presented with functional somatic symptoms, constipation, hyperhidrosis and sleep disorders than controls. Patients also more frequently experienced more than one prodromal symptom and were more often referred within the primary care team or to a medical specialist.
CONCLUSIONS: Prodromal symptoms of PD are encountered in general practice. GPs should be alert when patients present with multiple prodromal symptoms in a two-year period, especially considering the benefits of early intervention, and the future possibilities for disease-modifying therapy.
© The Author 2014. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Early diagnosis; Parkinson disease; general practice; prodromal symptoms; somatoform disorders.

Mesh:

Year:  2014        PMID: 24869632     DOI: 10.1093/fampra/cmu025

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  12 in total

Review 1.  Advances in markers of prodromal Parkinson disease.

Authors:  Ronald B Postuma; Daniela Berg
Journal:  Nat Rev Neurol       Date:  2016-10-27       Impact factor: 42.937

2.  Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease.

Authors:  Cameron Miller-Patterson; Jesse Y Hsu; Lana M Chahine; James F Morley; Allison W Willis
Journal:  Clin Auton Res       Date:  2022-09-03       Impact factor: 5.625

Review 3.  Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Authors:  Sebastian Heinzel; Benjamin Roeben; Yoav Ben-Shlomo; Stefanie Lerche; Guido Alves; Paolo Barone; Stefanie Behnke; Henk W Berendse; Bastiaan R Bloem; David Burn; Richard Dodel; Donald G Grosset; Michele Hu; Meike Kasten; Rejko Krüger; Marcello Moccia; Brit Mollenhauer; Wolfgang Oertel; Ulrike Suenkel; Uwe Walter; Karin Wirdefeldt; Inga Liepelt-Scarfone; Walter Maetzler; Daniela Berg
Journal:  Front Aging Neurosci       Date:  2016-06-22       Impact factor: 5.750

Review 4.  Nicotine from cigarette smoking and diet and Parkinson disease: a review.

Authors:  Chaoran Ma; Yesong Liu; Samantha Neumann; Xiang Gao
Journal:  Transl Neurodegener       Date:  2017-07-02       Impact factor: 8.014

Review 5.  The underlying mechanism of prodromal PD: insights from the parasympathetic nervous system and the olfactory system.

Authors:  Shu-Ying Liu; Piu Chan; A Jon Stoessl
Journal:  Transl Neurodegener       Date:  2017-02-20       Impact factor: 8.014

6.  The diagnostic pathway of Parkinson's disease: a cross-sectional survey study of factors influencing patient dissatisfaction.

Authors:  Annette O A Plouvier; Tim C Olde Hartman; Olga A de Bont; Sjoerd Maandag; Bastiaan R Bloem; Chris van Weel; Antoine L M Lagro-Janssen
Journal:  BMC Fam Pract       Date:  2017-08-25       Impact factor: 2.497

7.  Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations.

Authors:  Anette Schrag; Zacharias Anastasiou; Gareth Ambler; Alastair Noyce; Kate Walters
Journal:  Mov Disord       Date:  2019-02-08       Impact factor: 10.338

8.  Determinants of diagnostic latency in Chinese people with Parkinson's disease.

Authors:  Ying Wan; Yingying Zhu; Yi Luo; Xun Han; Yongsheng Li; Jing Gan; Na Wu; Anmu Xie; Zhenguo Liu
Journal:  BMC Neurol       Date:  2019-06-11       Impact factor: 2.474

9.  Probing the Pre-diagnostic Phase of Parkinson's Disease in Population-Based Studies.

Authors:  Lisanne J Dommershuijsen; Agnita J W Boon; M Kamran Ikram
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

10.  Autonomic dysfunction and white matter microstructural changes in drug-naïve patients with Parkinson's disease.

Authors:  Amir Ashraf-Ganjouei; Alireza Majd; Ali Javinani; Mohammad Hadi Aarabi
Journal:  PeerJ       Date:  2018-09-13       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.